Consolidated Portfolio Review Corp’s iShares iBonds Dec 2025 Term Treasury ETF IBTF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-48,051
Closed -$1.12M 203
2025
Q3
$1.12M Buy
48,051
+2,988
+7% +$69.7K 0.14% 161
2025
Q2
$1.05M Buy
45,063
+3,485
+8% +$81.3K 0.15% 156
2025
Q1
$972K Buy
41,578
+5,349
+15% +$125K 0.16% 151
2024
Q4
$845K Buy
36,229
+4,511
+14% +$105K 0.13% 172
2024
Q3
$743K Buy
31,718
+1,326
+4% +$30.9K 0.17% 153
2024
Q2
$706K Buy
30,392
+2,754
+10% +$63.8K 0.16% 153
2024
Q1
$642K Buy
27,638
+1,564
+6% +$36.4K 0.17% 140
2023
Q4
$607K Buy
26,074
+1,421
+6% +$32.9K 0.14% 155
2023
Q3
$569K Buy
24,653
+342
+1% +$7.89K 0.14% 161
2023
Q2
$562K Buy
24,311
+302
+1% +$7.06K 0.13% 156
2023
Q1
$565K Buy
+24,009
New +$561K 0.15% 147

Other funds holding IBTF

Consolidated Portfolio Review Corp's IBTF Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of iShares iBonds Dec 2025 Term Treasury ETF (IBTF) in Q4 2025, closing a stake of 48,051 shares — an estimated $1.12M sold.

Consolidated Portfolio Review Corp first reported a position in IBTF in Q1 2023 and held it in 11 quarters. The position peaked at $1.12M in Q3 2025. 2 funds tracked by Wall St. Rank hold IBTF as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining iShares iBonds Dec 2025 Term Treasury ETF position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 48,051 iShares iBonds Dec 2025 Term Treasury ETF shares in Q4 2025, an estimated $1.12M.
  • Consolidated Portfolio Review Corp first reported a position in iShares iBonds Dec 2025 Term Treasury ETF in Q1 2023 and held it in 11 quarters.
  • Consolidated Portfolio Review Corp's iShares iBonds Dec 2025 Term Treasury ETF position peaked at $1.12M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Treasury ETF as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.